相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pasireotide and Octreotide Stimulate Distinct Patterns of sst2A Somatostatin Receptor Phosphorylation
Florian Poell et al.
MOLECULAR ENDOCRINOLOGY (2010)
Agonist-Biased Signaling at the sst2A Receptor: The Multi-Somatostatin Analogs KE108 and SOM230 Activate and Antagonize Distinct Signaling Pathways
Renzo Cescato et al.
MOLECULAR ENDOCRINOLOGY (2010)
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Richard A. Feelders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Significant response to pasireotide (SOM230) in the treatment of a patient with persistent, refractory Cushing's disease
Kimberly Cukier et al.
CLINICAL ENDOCRINOLOGY (2009)
Merits and pitfalls of mifepristone in Cushing's syndrome
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
Anat Ben-Shlomo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Treatment of Pituitary-Dependent Cushing's Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
M. Boscaro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Trafficking in Vitro
Sarah Lesche et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Differential regulation of human dopamine D-2 and somatostatin receptor subtype expression by glucocorticoids in vitro
C. de Bruin et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
Diego Ferone et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)
Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response
Anat Ben-Shlomo et al.
MOLECULAR ENDOCRINOLOGY (2009)
Site Specificity of Agonist and Second Messenger-Activated Kinases for Somatostatin Receptor Subtype 2A (Sst2A) Phosphorylation
Qisheng Liu et al.
MOLECULAR PHARMACOLOGY (2009)
Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome
C. de Bruin et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience
John T. Chow et al.
CLINICAL ENDOCRINOLOGY (2008)
Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumours
Nicole Unger et al.
CLINICAL ENDOCRINOLOGY (2008)
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Pituitary-targeted medical therapy of Cushing's disease
Krystallenia I. Alexandraki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly
Robert D. Murray et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Late recurrences of Cushing's disease after initial successful transsphenoidal surgery
Chirag G. Patil et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement
B. M. K. Biller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas
Joshua H. Petit et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The diagnosis of Cushing's syndrome: An endocrine society clinical practice guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging
Daniel M. Prevedello et al.
JOURNAL OF NEUROSURGERY (2008)
Somatostatin and somatostatin receptors in Cushing's disease
Leo J. Hofland
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Dimerization of G protein-coupled receptors: New avenues for somatostatin receptor signalling, control and functioning
Mario Duran-Prado et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Selective agonism in somatostatin receptor signaling and regulation
Agnes Schonbrunn
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Pasireotide (SOM230): Development, mechanism of action and potential applications
Herbert A. Schmid
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Intracellular trafficking of somatostatin receptors
Stefan Jacobs et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field
V. A. S. H. Dalm et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization
Michael Grant et al.
MOLECULAR ENDOCRINOLOGY (2008)
Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease
Chirag G. Patil et al.
NEUROSURGERY (2008)
Management of recurrent and refractory Cushing disease
Manish K. Aghi
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Octreotide and the novel multireceptor ligand somatostatin receptor agonist pasireotide (SOM230) block the adrenalectomy-induced increase in mitotic activity in male rat anterior pituitary
L. A. Nolan et al.
ENDOCRINOLOGY (2007)
Gamma Knife surgery for Cushing's disease
Jay Jagannathan et al.
JOURNAL OF NEUROSURGERY (2007)
Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease - A 10-year experience
Sarah K. Thompson et al.
ANNALS OF SURGERY (2007)
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas
Monica Fedele et al.
CLINICAL CANCER RESEARCH (2007)
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion
Maria Chiara Zatelli et al.
ENDOCRINE-RELATED CANCER (2007)
Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Corticotroph tumor progression after adrenalectomy in Cushing's disease:: A reappraisal of Nelson's syndrome
Guillaume Assie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas
Dalia L. Batista et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance
AB Atkinson et al.
CLINICAL ENDOCRINOLOGY (2005)
Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells
J van der Hoek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly
PM Ma et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion
A Ben-Shlomo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The metabolic syndrome and cardiovascular risk in Cushing's syndrome
R Pivonello et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2005)
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
LJ Hofland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro
LJ Hofland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients
J van der Hoek et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effects of chronic administration of PPAR-γ ligand rosiglitazone in Cushing's disease
B Ambrosi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Transsphenoidal microsurgery for Cushing's disease: Initial outcome and long-term results
GD Hammer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Dopamine receptor expression and function in corticotroph pituitary tumors
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Diagnosis and complications of Cushing's syndrome: A consensus statement
G Arnaldi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion
SG Ren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs
D Cervia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
The pathophysiological consequences of somatostatin receptor internalization and resistance
LJ Hofland et al.
ENDOCRINE REVIEWS (2003)
Opportunities in somatostatin research: Biological, chemical and therapeutic aspects
G Weckbecker et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
AP Heaney et al.
NATURE MEDICINE (2002)
SOM230: A new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs
G Weckbecker et al.
ENDOCRINOLOGY (2002)
Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormone-stimulated adrenocorticotropin secretion from AtT-20 cells
MZ Strowski et al.
NEUROENDOCRINOLOGY (2002)
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
C Bruns et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
分享论文
